Iron Deficiency and Anaemia in Heart Failure: Understanding the FAIR-HF Trial

José González-Costello; Josep Comín-Colet


Eur J Heart Fail. 2010;12(11):1159-1162. 

In This Article


After the positive findings of the FAIR-HF trial, there is a need for cardiologists to study the iron metabolism of patients with CHF, and it seems reasonable to undertake a work-up evaluation if absolute or functional ID is found and start treatment with IV iron, although mortality and morbidity studies would help to further define the role of IV iron in CHF and its usefulness associated with ESA agents in patients with anaemia and CHF.